Company: MDCXW
Filing Date: 2025-06-30
Form Type: DEF 14A
Source: 0001062993-25-012273
Chunk: 49

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-30
Form: DEF 14A
Chunk 49
---
 plan, the performance of the auditors, and the results of the external audit and the report thereon;

monitoring and periodically reviewing our corporate policies and associated procedures, and hiring policies; and

providing broad oversight of our financial, risk and control related activities.

The Audit Committee has unrestricted access to all information regarding the Company and all our directors, officers and employees and will be directed to cooperate as requested by the Audit Committee. The Audit Committee has the authority to retain, at our expense, outside legal, financial and other advisors, consultants and experts, to assist the Audit Committee in fulfilling its duties and responsibilities. The Audit Committee also has the authority to communicate directly with the auditors and, if applicable, our internal auditors.

Audit Committee Oversight

On December 19, 2024, MNP resigned its position as the independent registered public accounting firm of the Company. The resignation of MNP has been approved by the Audit Committee and the Board. The appointment of EisnerAmper LLP has been approved by the Audit Committee and the Board, effective December 19, 2024. Except as disclosed above, during the Company's financial year ended December 31, 2024, no recommendations of the Audit Committee to nominate or compensate an external auditor were adopted by the Board.

EisnerAmper served as the independent registered public accounting firm of the Company from December 19, 2024 to June 3, 2025. The Company dismissed EisnerAmper from its position as the independent registered public accounting firm of the Company effective June 3, 2025. The dismissal of EisnerAmper was recommended by the Audit Committee and has been approved by the Board. The appointment of KPMG has been approved by the Audit Committee and the Board, effective June 4, 2025.

See "Change in Independent Auditor" under "Proposal 1 - Appointment and Remuneration of Auditors" in this proxy statement.

<div align='center'>39</div>

Compensation Committee

The purpose of the Compensation Committee is to assess and make recommendations to the Board regarding certain compensation matters, including, but not limited to, relating to the development of human resource strategy, policies and programs, the proper utilization of human resources within the Company, with special focus on senior management succession, development and compensation, the compensation of directors and senior executives and other employee benefits.

The Compensation Committee is required to review and assess the adequacy of its charter periodically as conditions dictate, but at least annually, to ensure compliance